Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2401 Injection in COPD

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07330310) titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2401 Injection in COPD' on Dec. 29, 2025.

Brief Summary: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous JKN2401 Injection in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Intervention: BIOLOGICAL: JKN2401 Injection

JKN2401 subcutaneous injection, Q4W

OTHER: Placebo

Placebo subcutaneous injection,Q4W

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ...